+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Intragastric Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • ID: 5118175
  • Report
  • June 2020
  • Region: Global
  • 108 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Apollo Endosurgery
  • Endalis
  • Lexel SRL
  • Medsil
  • PlenSat
  • Silimed Inc.
  • MORE
The global intragastric balloons market is currently exhibiting strong growth. An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing weight. It is inserted through a non-surgical endoscopic procedure to confine the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in preserving the anatomy of the stomach and is bio-compatible while having negligible or no side-effects. As a result, the device is commonly used by individuals suffering from obesity and having a body mass index (BMI) ranging from 30 to 70.

The increasing prevalence of obesity is one of the key factors driving the growth of the market. Owing to sedentary lifestyles and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. This has consequently augmented the demand for various medically certified weight-loss procedures, including intragastric balloons. Furthermore, growing consumer preference for minimally invasive (MI) surgeries is also providing a boost to the market growth. Intragastric balloons serve as an effective non-surgical alternative for weight-loss as they are inserted orally and do not require any incisions on the body. Additionally, various technological advancements and product innovations are also creating a positive outlook for the market growth. Manufacturers are focusing on creating product variants with minimal side-effects, such as ulceration, gastric erosion and nausea, and are also designing balloons with adjustable gas/saline volumes. Other factors, including increasing health consciousness among consumers, and extensive research and development (R&D) activities, are projected to drive the market further. Looking forward, the publisher expects the market to grow at a CAGR of around 6% during 2020-2025.

Breakup by Product:
  • Single Intra Gastric Balloon
  • Double Intra Gastric Balloon
  • Triple Intra Gastric Balloon
Breakup by Filling Material:
  • Saline Filling
  • Gas Filling
Breakup by Implanting Procedure:
  • Surgical
  • Non-Surgical
Breakup by Application:
  • Obesity
  • Diabetes
  • Diet Control
  • Weight-Loss
  • Pre-Operative Weight Reduction
  • Others
Breakup by End-User:
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Apollo Endosurgery, Obalon Therapeutics Inc., ReShape Medical Inc., Medicone, Medsil, Allurion Technologies Inc., Helioscopie, Spatz Fgia Inc., PlenSat, Districlass Medical SA, Endalis, Lexel SRL, Silimed Inc., Shandong Institute of Medical Instruments, etc.

Key Questions Answered in this Report:
  • How has the global intragastric balloons market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the filling material?
  • What is the breakup of the market based on the implanting procedure?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global intragastric balloons market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Apollo Endosurgery
  • Endalis
  • Lexel SRL
  • Medsil
  • PlenSat
  • Silimed Inc.
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Intragastric Balloons Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Product
6.1 Single Intra Gastric Balloon
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Double Intra Gastric Balloon
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Triple Intra Gastric Balloon
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Filling Material
7.1 Saline Filling
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Gas Filling
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Implanting Procedure
8.1 Surgical
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Non-Surgical
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by Application
9.1 Obesity
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diabetes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diet Control
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Weight-Loss
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Pre-Operative Weight Reduction
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast

10 Market Breakup by End-User
10.1 Hospitals and Clinics
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Ambulatory Surgical Centers
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast

11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Apollo Endosurgery
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Obalon Therapeutics Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 ReShape Medical Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Medicone
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Medsil
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Allurion Technologies Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Helioscopie
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Spatz Fgia Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 PlenSat
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Districlass Medical SA
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.11 Endalis
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Lexel SRL
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.13 Silimed Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.14 Shandong Institute of Medical Instruments
16.3.14.1 Company Overview
16.3.14.2 Product Portfolio
Note: Product cover images may vary from those shown
3 of 4
  • Apollo Endosurgery
  • Obalon Therapeutics Inc.
  • ReShape Medical Inc.
  • Medicone
  • Medsil
  • Allurion Technologies Inc.
  • Helioscopie
  • Spatz Fgia Inc.
  • PlenSat
  • Districlass Medical SA
  • Endalis
  • Lexel SRL
  • Silimed Inc.
  • Shandong Institute of Medical Instruments
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll